---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-112592"
form_type: "8-K"
ticker: "PTGX"
cik: "0001377121"
company_name: "Protagonist Therapeutics, Inc"
filed_at: "2023-10-30T23:59:59+00:00"
generated_at: "2026-06-09T05:43:57.159348+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Protagonist Therapeutics expands board to 7, appoints Daniel Swisher as director

## Summary
- Board increased from 6 to 7 directors; Daniel N. Swisher, Jr. appointed as Class I director effective Oct 26, 2023.
- Swisher most recently President of Jazz Pharmaceuticals (2018-2023); also serves on boards of Cerus and Corcept.
- Receives $40,000 annual cash retainer and option for 45,000 shares at $14.21, vesting over 36 months.
- Standard indemnification agreement entered; term runs until 2026 annual meeting.
- No arrangements or family relationships with other directors or officers.

## SEC filing metadata
- accession: 0001104659-23-112592
- form_type: 8-K
- ticker: PTGX
- cik: 0001377121
- company_name: Protagonist Therapeutics, Inc
- filed_at: 2023-10-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1377121/000110465923112592/0001104659-23-112592-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1377121/000110465923112592/tm2329380d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-112592
- JSON: https://secwatch.observer/filing/0001104659-23-112592.json
- Plain text: https://secwatch.observer/filing/0001104659-23-112592.txt

## Key facts
- Executive change
  Daniel N. Swisher, Jr. was appointed as Class I Director at Protagonist Therapeutics, Inc.
  - Action: appointed
  - Role: Class I Director
  source text: appointed Daniel N. Swisher, Jr. to serve as a Class I director
  evidence_url: https://www.sec.gov/Archives/edgar/data/1377121/000110465923112592/0001104659-23-112592-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.